Bio-Rad Laboratories, Inc. (BIO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:08AM EDT. Market open.
| Previous close | 471.78 |
| Open | 471.78 |
| Bid | 473.51 x 1100 |
| Ask | 477.10 x 800 |
| Day's range | 469.70 - 475.41 |
| 52-week range | 344.63 - 607.54 |
| Volume | |
| Avg. volume | 171,603 |
| Market cap | 13.8B |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | 3.49 |
| EPS (TTM) | 135.87 |
| Earnings date | 26 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 592.20 |
- Zacks
Verano Holdings Corp. (VRNOF) Q4 Earnings Surpass Estimates
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 300% and 0.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
A Look At The Fair Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Key Insights The projected fair value for Bio-Rad Laboratories is US$452 based on 2 Stage Free Cash Flow to Equity...
- Zacks
Select Medical's (SEM) Orlando Facility to Boost Post-Acute Care
Select Medical (SEM) aims to address the post-acute care demand in the Central Florida region through the construction of a specialty hospital in Orlando.
© 2023 Yahoo. All rights reserved.
